UCD School of Medicine receives €2.5 million funding from HRB (Health Research Board), in partnership with the CHI (Children’s Health Ireland) Cancer Trials Group, to enhance children and adolescent cancer patient-focused research. The programme aims to increase opportunities for child and adolescent cancer patients to participate in clinical trials and increase the critical support available to investigators from facilities to sponsorship.
